{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:12:29Z","timestamp":1760184749076,"version":"build-2065373602"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.hoc.2008.03.007","type":"journal-article","created":{"date-parts":[[2008,5,29]],"date-time":"2008-05-29T06:22:56Z","timestamp":1212042176000},"page":"443-455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Molecular Pathology of Thymic Epithelial Neoplasms"],"prefix":"10.1016","volume":"22","author":[{"given":"Elisabetta","family":"Kuhn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio I.","family":"Wistuba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hoc.2008.03.007_bib1","series-title":"WHO International Classification of Tumours","first-page":"65","article-title":"Histological typing of tumours of the thymus","author":"Rosai","year":"1999"},{"key":"10.1016\/j.hoc.2008.03.007_bib2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0022-5223(98)70273-9","article-title":"Thymic carcinoma: current staging does not predict prognosis","volume":"115","author":"Blumberg","year":"1998","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.hoc.2008.03.007_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/cncr.10588","article-title":"Treatment and prognosis of thymic carcinoma: a retrospective analysis of 40 cases","volume":"94","author":"Ogawa","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2008.03.007_bib4","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0002-9440(10)64426-4","article-title":"Chromosome 6 suffers frequent and multiple aberrations in thymoma","volume":"161","author":"Inoue","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.hoc.2008.03.007_bib5","first-page":"3708","article-title":"Correlating genetic aberrations with World Health Organization-defined histology and stage across the spectrum of thymomas","volume":"63","author":"Inoue","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.hoc.2008.03.007_bib6","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/ijc.11101","article-title":"Clusters of chromosomal imbalances in thymic epithelial tumours are associated with the WHO classification and the staging system according to Masaoka","volume":"105","author":"Penzel","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.hoc.2008.03.007_bib7","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/ijc.10624","article-title":"Gene expression analysis of human thymoma correlates with tumor stage","volume":"101","author":"Sasaki","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.hoc.2008.03.007_bib8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0002-9440(10)64536-1","article-title":"Recurrent genetic aberrations in thymoma and thymic carcinoma","volume":"157","author":"Zettl","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.hoc.2008.03.007_bib9","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0002-9440(10)63031-3","article-title":"Thymic epithelial tumors can develop along two different pathogenetic pathways","volume":"159","author":"Zhou","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.hoc.2008.03.007_bib10","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0022-5223(20)31934-6","article-title":"Thymoma: a clinicopathologic study","volume":"42","author":"Bernatz","year":"1961","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.hoc.2008.03.007_bib11","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/00000478-199212000-00003","article-title":"Well-differentiated thymic carcinoma. An organotypical low-grade carcinoma with relationship to cortical thymoma","volume":"16","author":"Kirchner","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.hoc.2008.03.007_bib12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF00737071","article-title":"Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus","volume":"407","author":"Marino","year":"1985","journal-title":"Virchows Arch A\u00a0Pathol Anat Histopathol"},{"key":"10.1016\/j.hoc.2008.03.007_bib13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00277-002-0597-6","article-title":"Malignant thymoma: current status of classification and multimodality treatment","volume":"82","author":"Schmidt-Wolf","year":"2003","journal-title":"Ann Hematol"},{"key":"10.1016\/j.hoc.2008.03.007_bib14","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/ajcp\/111.6.826","article-title":"Thymoma, atypical thymoma, and thymic carcinoma. A novel conceptual approach to the classification of thymic epithelial neoplasms","volume":"111","author":"Suster","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.hoc.2008.03.007_bib15","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1309\/CAV8RNU5TKNACKNC","article-title":"Thymoma classification: current status and future trends","volume":"125","author":"Suster","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.hoc.2008.03.007_bib16","first-page":"221","article-title":"Genetic instability and tumor development","volume":"57","author":"Nowell","year":"1991","journal-title":"Basic Life Sci"},{"key":"10.1016\/j.hoc.2008.03.007_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.hoc.2008.03.007_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijrobp.2003.11.041","article-title":"Review of epidermal growth factor receptor biology","volume":"59","author":"Herbst","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hoc.2008.03.007_bib19","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/cncr.20811","article-title":"Protein expression and gene amplification of epidermal growth factor receptor in thymomas","volume":"103","author":"Ionescu","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2008.03.007_bib20","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.canlet.2006.07.003","article-title":"Mutational status of the epidermal growth factor receptor (EGFR) gene in thymomas and thymic carcinomas","volume":"248","author":"Meister","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.hoc.2008.03.007_bib21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/jjco\/hyl028","article-title":"Expression and mutation statuses of epidermal growth factor receptor in thymic epithelial tumors","volume":"36","author":"Suzuki","year":"2006","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.hoc.2008.03.007_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00194697","article-title":"Thymoma: tumour type related to expression of epidermal growth factor (EGF), EGF-receptor, p53, v-erb B and ras p21","volume":"426","author":"Hayashi","year":"1995","journal-title":"Virchows Arch"},{"key":"10.1016\/j.hoc.2008.03.007_bib23","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00432-004-0545-z","article-title":"Tyrosine kinase receptor expression in thymomas","volume":"130","author":"Henley","year":"2004","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.hoc.2008.03.007_bib24","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00432-001-0319-9","article-title":"Epidermal growth factor receptor expression in invasive thymoma","volume":"128","author":"Henley","year":"2002","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.hoc.2008.03.007_bib25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-2559.2003.01663.x","article-title":"Expression of apoptosis-related markers and HER-2\/neu in thymic epithelial tumours","volume":"43","author":"Pan","year":"2003","journal-title":"Histopathology"},{"key":"10.1016\/j.hoc.2008.03.007_bib26","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1378\/chest.128.1.140","article-title":"Immunohistochemical KIT (CD117) expression in thymic epithelial tumors","volume":"128","author":"Nakagawa","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.hoc.2008.03.007_bib27","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/path.1514","article-title":"KIT (CD117) is frequently overexpressed in thymic carcinomas but is absent in thymomas","volume":"202","author":"Pan","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.hoc.2008.03.007_bib28","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1056\/NEJM200406173502523","article-title":"Thymic carcinoma with overexpression of mutated KIT and the response to imatinib","volume":"350","author":"Strobel","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2008.03.007_bib29","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrc1097","article-title":"RAS oncogenes: the first 30 years","volume":"3","author":"Malumbres","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.hoc.2008.03.007_bib30","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1365-2559.1997.5730805.x","article-title":"Expression of p53, mdm2, p21\/waf1 and bcl-2 proteins in thymomas","volume":"30","author":"Stefanaki","year":"1997","journal-title":"Histopathology"},{"key":"10.1016\/j.hoc.2008.03.007_bib31","first-page":"1621","article-title":"Aberrant methylation: common in thymic carcinomas, rare in thymomas","volume":"14","author":"Suzuki","year":"2005","journal-title":"Oncol Rep"},{"key":"10.1016\/j.hoc.2008.03.007_bib32","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1002\/cncr.21433","article-title":"Long-term disease-free survival of patients with radically resected thymomas: relevance of cell-cycle protein expression","volume":"104","author":"Mineo","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2008.03.007_bib33","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1002\/1097-0142(19890515)63:10<1888::AID-CNCR2820631004>3.0.CO;2-L","article-title":"Hereditary cancers disclose a class of cancer genes","volume":"63","author":"Knudson","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2008.03.007_bib34","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/carcin\/17.6.1187","article-title":"p53 Tumor suppressor gene: from the basic research laboratory to the clinic\u2014an abridged historical perspective","volume":"17","author":"Harris","year":"1996","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.hoc.2008.03.007_bib35","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0046-8177(96)90289-0","article-title":"Detection of bcl-2 and p53 in thymoma: expression of bcl-2 as a reliable marker of tumor aggressiveness","volume":"27","author":"Chen","year":"1996","journal-title":"Hum Pathol"},{"key":"10.1016\/j.hoc.2008.03.007_bib36","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/(SICI)1097-0215(19971127)73:5<639::AID-IJC5>3.0.CO;2-Y","article-title":"p16INK4, pRB, p53 and cyclin D1 expression and hypermethylation of CDKN2 gene in thymoma and thymic carcinoma","volume":"73","author":"Hirabyashi","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.hoc.2008.03.007_bib37","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/(SICI)1097-0215(19960621)69:3<180::AID-IJC5>3.0.CO;2-W","article-title":"p53 expression and proliferative activity predict survival in non-invasive thymomas","volume":"69","author":"Pich","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1016\/j.hoc.2008.03.007_bib38","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/ajcp\/104.4.375","article-title":"p53 protein expression and p53 gene mutation in thymic epithelial tumors. An immunohistochemical and DNA sequencing study","volume":"104","author":"Tateyama","year":"1995","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.hoc.2008.03.007_bib39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s004280050064","article-title":"p53 alterations in thymic epithelial tumours","volume":"431","author":"Weirich","year":"1997","journal-title":"Virchows Arch"},{"key":"10.1016\/j.hoc.2008.03.007_bib40","first-page":"F21","article-title":"Progress in understanding the molecular pathogenesis of human lung cancer","volume":"1378","author":"Sekido","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.hoc.2008.03.007_bib41","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1535-6108(02)00027-2","article-title":"Focus on lung cancer","volume":"1","author":"Minna","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.hoc.2008.03.007_bib42","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1056\/NEJMra023075","article-title":"Gene silencing in cancer in association with promoter hypermethylation","volume":"349","author":"Herman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2008.03.007_bib43","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1699-0463.1998.tb01370.x","article-title":"Expression of bcl-2 in fetal thymus, thymomas and thymic carcinomas. Association with p53 expression and review of the literature","volume":"106","author":"Engel","year":"1998","journal-title":"APMIS"},{"key":"10.1016\/j.hoc.2008.03.007_bib44","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1097\/01.MP.0000038463.67854.84","article-title":"Proliferative activity and apoptosis in thymic epithelial neoplasms","volume":"15","author":"Hiroshima","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.hoc.2008.03.007_bib45","first-page":"983","article-title":"Apoptosis, bcl-2 protein, and Fas antigen in thymic epithelial tumors","volume":"10","author":"Tateyama","year":"1997","journal-title":"Mod Pathol"},{"key":"10.1016\/j.hoc.2008.03.007_bib46","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nrc2293","article-title":"Survivin, cancer networks and pathway-directed drug discovery","volume":"8","author":"Altieri","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.hoc.2008.03.007_bib47","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/hmg\/10.7.677","article-title":"Telomerase and cancer","volume":"10","author":"Shay","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.hoc.2008.03.007_bib48","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/cncr.10194","article-title":"Enhanced expression of telomerase activity in thymoma and thymic carcinoma tissues: a clinicopathologic study","volume":"94","author":"Watanabe","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2008.03.007_bib49","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/106689690401200412","article-title":"KI-67 antigen expression predicts survival and correlates with histologic subtype in the WHO classification of thymic epithelial tumors","volume":"12","author":"Comin","year":"2004","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.hoc.2008.03.007_bib50","doi-asserted-by":"crossref","first-page":"4258s","DOI":"10.1158\/1078-0432.CCR-040023","article-title":"Anti-vascular endothelial growth factor monoclonals in non-small cell lung cancer","volume":"10","author":"Sandler","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.hoc.2008.03.007_bib51","first-page":"65","article-title":"The role of angiogenesis in tumor growth","volume":"3","author":"Folkman","year":"1992","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.hoc.2008.03.007_bib52","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1093\/emboj\/18.14.3964","article-title":"VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells","volume":"18","author":"Asahara","year":"1999","journal-title":"Embo J"},{"key":"10.1016\/j.hoc.2008.03.007_bib53","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1046\/j.1523-1755.1999.00610.x","article-title":"Role of vascular endothelial growth factor in the regulation of angiogenesis","volume":"56","author":"Ferrara","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.hoc.2008.03.007_bib54","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrd2115","article-title":"Angiogenesis: an organizing principle for drug discovery?","volume":"6","author":"Folkman","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.hoc.2008.03.007_bib55","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1067\/mtc.2002.124389","article-title":"Correlation between tumor angiogenesis and invasiveness in thymic epithelial tumors","volume":"124","author":"Tomita","year":"2002","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.hoc.2008.03.007_bib56","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1007\/s005950170021","article-title":"Elevated serum vascular endothelial growth factor and basic fibroblast growth factor levels in patients with thymic epithelial neoplasms","volume":"31","author":"Sasaki","year":"2001","journal-title":"Surg Today"},{"key":"10.1016\/j.hoc.2008.03.007_bib57","first-page":"111","article-title":"Tissue inhibitors of metalloproteinases: structure, regulation and biological functions","volume":"74","author":"Gomez","year":"1997","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.hoc.2008.03.007_bib58","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jso.1030","article-title":"Activation of matrix metalloproteinase-2 is correlated with invasiveness in thymic epithelial tumors","volume":"76","author":"Kondo","year":"2001","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.hoc.2008.03.007_bib59","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.humpath.2003.07.013","article-title":"Expression of matrix metalloproteinases 2 and 7\u00a0in tumor cells correlates with the World Health Organization classification subtype and\u00a0clinical stage of thymic epithelial tumors","volume":"34","author":"Takahashi","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.hoc.2008.03.007_bib60","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/cncr.11725","article-title":"Increased expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 is correlated with poor prognostic variables in patients with thymic epithelial tumors","volume":"98","author":"Sogawa","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2008.03.007_bib61","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1359641","article-title":"Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors","volume":"258","author":"Kallioniemi","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.hoc.2008.03.007_bib62","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/1471-2164-8-305","article-title":"Genome-wide genetic aberrations of thymoma using cDNA microarray based comparative genomic hybridization","volume":"8","author":"Lee","year":"2007","journal-title":"BMC Genomics"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858808000312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858808000312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:51:11Z","timestamp":1760183471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858808000312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0889858808000312"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2008.03.007","relation":{},"ISSN":["0889-8588"],"issn-type":[{"type":"print","value":"0889-8588"}],"subject":[],"published":{"date-parts":[[2008,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Pathology of Thymic Epithelial Neoplasms","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2008.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}